Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 2057 | 547 | 0.2157 | 0.2671 | 0.2659 | 0.2394 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 1 | 792 | 31 | 0.7705 | 0.6021 | 0.0391 | 0.0426 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 2 | 619 | 26 | 0.6004 | 0.6021 | 0.0420 | 0.0426 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 1135 | 66 | 0.8529 | 1.0000 | 0.0581 | 0.0496 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 1504 | 69 | 1.1449 | 1.0000 | 0.0459 | 0.0496 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 1846 | 89 | 1.4019 | 1.3011 | 0.0482 | 0.0459 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 1386 | 59 | 1.0588 | 0.8133 | 0.0426 | 0.0417 |
COLO 858 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 7914 | 1171 | 0.9632 | 1.0000 | 0.1480 | 0.1514 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 850 | 32 | 0.6527 | 0.8133 | 0.0376 | 0.0417 |
COLO 858 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 8309 | 1285 | 1.0034 | 1.0000 | 0.1547 | 0.1514 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 696 | 30 | 0.5314 | 0.8059 | 0.0431 | 0.0432 |
COLO 858 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 8526 | 1292 | 1.0334 | 1.0000 | 0.1515 | 0.1514 |
MZ7-mel | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 5344 | 345 | 1.0053 | 1.0000 | 0.0646 | 0.0602 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 19971 | 929 | 0.9642 | 1.0000 | 0.0465 | 0.0504 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 20360 | 1046 | 1.0111 | 1.0000 | 0.0514 | 0.0527 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 20251 | 1109 | 1.0021 | 1.0000 | 0.0548 | 0.0527 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 19884 | 1032 | 0.9869 | 1.0000 | 0.0519 | 0.0527 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 16059 | 813 | 0.7981 | 0.7489 | 0.0506 | 0.0459 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 14559 | 660 | 0.7276 | 0.7489 | 0.0453 | 0.0459 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 14373 | 599 | 0.7211 | 0.7489 | 0.0417 | 0.0459 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 9957 | 502 | 0.4950 | 0.4801 | 0.0504 | 0.0412 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 9020 | 322 | 0.4553 | 0.4801 | 0.0357 | 0.0412 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 9724 | 364 | 0.4900 | 0.4801 | 0.0374 | 0.0412 |
MZ7-mel | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 2499 | 153 | 0.4718 | 0.3781 | 0.0612 | 0.0626 |
MZ7-mel | Vemurafenib | Dasatinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 1537 | 88 | 0.2914 | 0.2872 | 0.0573 | 0.0593 |